Company Monitoring Page for JNJ

latest headlines for company on cafepharma

ASH: J&J's fast-growing Darzalex lines up for second front-line myeloma OK
Fierce Pharma
Tue, 12/4/18 - 11:33 am
Tags:
JNJ, Darzalex, Multiple Myeloma, ASH 2018
Should You Be Worried About the Return of Big Pharma Deals?
Motley Fool
Tue, 12/4/18 - 11:27 am
Tags:
GSK, Tesaro, M&A, Big Pharma, JNJ, Argenx
Vedanta pockets $12M from Johnson & Johnson on start of microbiome drug trial
Fierce Biotech
Wed, 11/28/18 - 10:04 am
Tags:
Vedanta Biosciences, JNJ, microbiome, IBD, VE202
Johnson & Johnson shares swoon as pharma giant loses yet another fight to protect Zytiga sales
Fierce Pharma
Tue, 11/27/18 - 12:12 pm
Tags:
JNJ, generics, Zytiga, Supreme Court, patents
J&J shares fall after court refuses to block Zytiga generics
Pharmaforum
Fri, 11/23/18 - 01:14 pm
Tags:
JNJ, generics, Zytiga, prostate cancer
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
BioSpace
Fri, 11/23/18 - 01:08 pm
Tags:
GSK, JNJ, Novartis, Merck KGaA, Sanofi, Takeda, developing countries
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Wed, 11/14/18 - 11:45 pm
Tags:
Pfizer, biosimilars, Amgen, Epogen, JNJ, Procrit, anemia
New Jersey Sues Janssen Pharmaceuticals Over Two Opioid Drugs
BioSpace
Wed, 11/14/18 - 11:42 pm
Tags:
New Jersey, opioids, JNJ, Janssen
J&J Vision inks $26m Singapore collaborative myopia research deal
Mass Device
Tue, 11/13/18 - 10:14 pm
Tags:
JNJ, vision, Singapore, myopia, devices
Pa. State Judge orders new trial in J&J pelvic mesh case
Mass Device
Fri, 11/9/18 - 11:35 am
Tags:
JNJ, devices, pelvic mesh, Ethicon
In another try at lung cancer niche, J&J nabs a potential Tagrisso rival for $50M-plus
Endpoints
Mon, 11/5/18 - 07:17 pm
Tags:
JNJ, Tagrisso, AstraZeneca, Yuhan
[video+transcript]How Geron's Horrible Year Is a Great Reminder to Investors
Motley Fool
Sun, 11/4/18 - 02:36 pm
Tags:
Geron, JNJ, imetelstat
Johnson & Johnson drops OSE’s rheumatoid arthritis drug
Fierce Biotech
Fri, 11/2/18 - 07:56 pm
Tags:
JNJ, OSE Immuotherapeutics, FR104, autoimmune disease, rheumatoid arthritis
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Forbes
Thu, 11/1/18 - 11:31 am
Tags:
Janssen, JNJ, Invokana, type 2 diabetes
Johnson & Johnson bags long-awaited cardiovascular nod for diabetes drug Invokana
Fierce Pharma
Wed, 10/31/18 - 11:52 am
Tags:
JNJ, Invokana, type 2 diabetes
Arrowhead Pharmaceuticals Closes Agreements with Janssen Worth Up To $3.7 Billion
CP Wire
Wed, 10/31/18 - 11:03 am
Tags:
Arrowhead Pharmaceuticals, Janssen, JNJ, hepatitis B
Wed, 10/31/18 - 10:25 am
Tags:
Arrowhead Pharmaceuticals, Janssen, JNJ
Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial
BioSpace
Tue, 10/30/18 - 12:06 pm
Tags:
JNJ, Janssen, Genmab, Darzalex, clinical trials, Multiple Myeloma
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
CP Wire
Tue, 10/30/18 - 10:22 am
Tags:
Janssen, JNJ, Symtuza, HIV
Johnson & Johnson to open JLabs virtual networking pod in Philadelphia
Fierce Biotech
Tue, 10/30/18 - 10:06 am
Tags:
JNJ, JLabs, JPod, innovation

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.